Skip to main content
. 2016 Jun 23;82(3):739–753. doi: 10.1111/bcp.12999

Figure 3.

Figure 3

PK metrics at steady state (left: C max, middle: AUC Plasma, right: AUC Lung), including overall model imprecision after oral olodaterol inhalation. Presented metrics are normalized to the median PK metric of standard healthy volunteer (BSA: 1.89 m2, non‐smoker, Caucasian). Points: normalized median PK metrics, lines: normalized 95% confidence intervals. AUC Plasma: area under the plasma concentration–time profile at steady‐state (0–24 h after inhalation, n = 14 doses), AUC Lung: Area under the unabsorbed amount–time profile at steady‐state (0–24 h after inhalation, n = 14), BSA: body surface area, “highest lung disposition scenario”: COPD, BSA 1.49 m2, smoker, and Asian